학술논문

Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 April 2024, 42(12):1350-1356)
Subject
Language
English
ISSN
15277755
0732183X